QID 376684

QID 376684: Spring Data MongoDB SpEL Expression Injection Vulnerability

A Spring Data MongoDB application is vulnerable to SpEL Injection when using @Query or @Aggregation-annotated query methods with SpEL expressions that contain query parameter placeholders for value binding if the input is not sanitized.
Specifically, an application is vulnerable when all of the following are true:

A repository query method is annotated with @Query or @Aggregation
The annotated query or aggregation value/pipeline contains SpEL parts using the parameter placeholder syntax within the expression
The user supplied input is not sanitized by the application

Affected VMware Products and Versions

Spring Data MongoDB:

3.4.0
3.3.0 to 3.3.4
Older, unsupported versions are also affected

A remote attacker can execute arbitrary code on the target system. Successful exploitation of this vulnerability may result in a complete compromise of a vulnerable system.

CVSS V3 rated as Critical - 9 severity.

CVSS V2 rated as High - 7.6 severity.

Solution

Users of affected versions should apply the following mitigation: 3.4.x users should upgrade to 3.4.1+. 3.3.x users should upgrade to 3.3.5+. No other steps are necessary.

Vendor References

Spring Data MongoDB SpEL Expression Injection Vulnerability - spring.io/blog/2022/06/20/spring-data-mongodb-spel-expression-injection-vulnerability-cve-2022-22980

CVEs related to QID 376684

CVE-2022-22980 |

Software Advisories

Advisory ID	Software	Component	Link
Spring			spring.io/blog/2022/06/20/spring-data-mongodb-spel-expression-injection-vulnerability-cve-2022-22980

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].